Xin Tong

Xin Tong

Harvard University

H-index: 8

North America-United States

About Xin Tong

Xin Tong, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Biochemistry, Immunology, Antibody.

His recent articles reflect a diverse array of research interests and contributions to the field:

Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses

Waning immunity and IgG4 responses following bivalent mRNA boosting

Compartment-Specific Antibody Correlates of Protection to SARS-CoV-2 Omicron in Macaques

Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination

Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins

Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

Efficacy of mRNA-1273 and Novavax ancestral or BA. 1 spike booster vaccines against SARS-CoV-2 BA. 5 infection in nonhuman primates

Synthesis, binding affinity, and inhibitory capacity of cyclodextrin-based multivalent glycan ligands for human galectin-3

Xin Tong Information

University

Position

Harvard Medical School

Citations(all)

421

Citations(since 2020)

379

Cited By

122

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

7

i10Index(since 2020)

7

Email

University Profile Page

Google Scholar

Xin Tong Skills & Research Interests

Biochemistry

Immunology

Antibody

Top articles of Xin Tong

Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses

Open Forum Infectious Diseases

2024/4

Waning immunity and IgG4 responses following bivalent mRNA boosting

Science Advances

2024/2/23

Compartment-Specific Antibody Correlates of Protection to SARS-CoV-2 Omicron in Macaques

bioRxiv

2024

Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination

The Journal of Immunology

2024/1/1

Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins

2023/12/19

Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

Nature Communications

2023/7/13

Efficacy of mRNA-1273 and Novavax ancestral or BA. 1 spike booster vaccines against SARS-CoV-2 BA. 5 infection in nonhuman primates

Science Immunology

2023/5/16

Synthesis, binding affinity, and inhibitory capacity of cyclodextrin-based multivalent glycan ligands for human galectin-3

Bioorganic & medicinal chemistry

2022/10/15

Transglycosylation of endo-S and endo-S mutants for antibody glycosylation remodeling

2022/10/4

Waning and boosting of functional humoral immunity to SARS-CoV-2

2022

Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines

Science translational medicine

2022/3/15

Preserved Omicron Spike specific antibody binding and Fc-recognition across COVID-19 vaccine platforms

medRxiv

2021/12/27

Simple, rapidly electroassembled thiolated PEG‐based sensor interfaces enable rapid interrogation of antibody titer and glycosylation

Biotechnology and Bioengineering

2021/7

Exploring a combined Escherichia coli-based glycosylation and in vitro transglycosylation approach for expression of glycosylated interferon alpha

Bioorganic & medicinal chemistry

2021/3/1

Generation and comparative kinetic analysis of new glycosynthase mutants from Streptococcus pyogenes endoglycosidases for antibody glycoengineering

2020/11/17

Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies

Proceedings of the National Academy of Sciences

2020/9/15

See List of Professors in Xin Tong University(Harvard University)